This bill matters because it addresses long-standing concerns about the ethics and effectiveness of using animals in medical research. Proponents argue that many animal studies don't accurately predict outcomes in humans, leading to high failure rates in human clinical trials. By prioritizing non-animal methods based on human biology, the bill aims to make research more relevant and potentially speed up the discovery of cures and treatments that work for people.

If this bill becomes law, it could lead to a significant shift in how taxpayer dollars are spent on medical research, moving towards innovative technologies like organoid cell cultures and 'in silico' (computer) trials. This could potentially reduce animal suffering, make research more cost-effective in the long run, and improve the success rate of developing new medicines. If it doesn't become law, current practices would likely continue, with less emphasis and dedicated resources for developing and implementing non-animal research alternatives within the NIH's vast research portfolio.